Evidence map›Paper›PMID 30804103›Full record

ArticleInfection and immunity2019

Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction.

Visnu Chaparro, Louis-Philippe Leroux, Aude Zimmermann, Armando Jardim, Brent Johnston, Albert Descoteaux, Maritza Jaramillo

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Infection and immunity · 2024
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Visnu ChaparroInstitut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.ORCID 0000-0001-6880-9234
Louis-Philippe LerouxInstitut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.ORCID 0000-0002-9736-1827
Aude ZimmermannInstitut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.
Armando JardimInstitute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
Brent JohnstonDepartments of Microbiology and Immunology and Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Albert DescoteauxInstitut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.ORCID 0000-0002-0633-5309
Maritza JaramilloInstitut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada maritza.jaramillo@iaf.inrs.ca.ORCID 0000-0002-1910-5684
Institut National de la Recherche Scientifique · CADalhousie University · CAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CXCL16 is a multifunctional chemokine that is highly expressed by macrophages and other immune cells in response to bacterial and viral pathogens; however, little is known regarding the role of CXCL16 during parasitic infections. The protozoan parasite

Indexed as

AnimalsChemokine CXCL16ChemotaxisDisease Models, AnimalGlycosphingolipidsHost-Parasite InteractionsHumansLeishmania donovaniLeishmaniasis, VisceralMiceMice, Inbred BALB CMice, Inbred C57BLChemokine CXCL16Glycosphingolipidslipophosphonoglycancell signalingchemokineCXCL16inflammationLeishmanialipophosphoglycanmacrophage

Identifiers

PMID30804103
PMCPMC6479025
OpenAlexW2917448431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.